PetCaseFinder

Peer-reviewed veterinary case report

Genetic cause of brain myelin problems in English Cocker Spaniel

By Gutierrez-Quintana, Rodrigo et al.·Published in Proceedings of the National Academy of Sciences of the United States of America·2026·School of Biodiversity, United Kingdom·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: A caninemissense variant differentiates oligodendrocyte maturation in connatal and classical Pelizaeus-Merzbacher disease.

Species:
dog

Plain-English summary

A group of English Cocker Spaniel puppies was found to have a serious condition called Pelizaeus-Merzbacher disease, which affects the nervous system and myelin formation. One male puppy showed severe tremors, trouble moving, and poor growth. Tests revealed significant damage to the central nervous system, with very little myelin present, which is crucial for proper nerve function. A specific genetic mutation was identified that likely caused these issues. Unfortunately, the affected puppy had a poor prognosis, but this case could help researchers understand similar conditions in both dogs and humans.

People also search for: English Cocker Spaniel tremors · puppy motor dysfunction · Pelizaeus-Merzbacher disease in dogs · dog myelin disorder · canine neurological problems

Abstract

Pelizaeus-Merzbacher disease (PMD) is an X-linked hypomyelinating disorder caused by pathogenic variants in the proteolipid protein () gene. We report a spontaneous canine dysmyelinating leukodystrophy in English Cocker Spaniel puppies. The most severely affected male pup displayed pronounced generalized tremors, progressive motor dysfunction, and markedly impaired growth. Histopathology at 5 wk of age revealed profound central nervous system (CNS) dysmyelination with no evidence of peripheral nerve involvement. Western blotting confirmed markedly reduced expression of CNS myelin-associated proteins. Ultrastructural analysis demonstrated a near absence of compact myelin, rare myelinated axons, and significant oligodendrocyte abnormalities, the majority of which had an immature cellular morphology. More mature, yet infrequent oligodendrocytes had distended rough endoplasmic reticula. Nucleotide sequence analysis identified a hemizygous c.92T>A missense variant in thegene predicted to cause a leucine-to-glutamine substitution in the first transmembrane domain, p.(L31Q). This variant was absent in over 1,600 public canine genomes and was predicted to be deleterious by multiple bioinformatic tools. Heterozygous females exhibited variable, transient clinical signs. We compared this canine leukodystrophy with the previously reportedand found that it represents a more severe phenotype recapitulating key clinical, pathological, and molecular features of severe connatal PMD in humans, including extreme CNS dysmyelination and associated neurological deficits. Interestingly, this genetic variant seems to cause a defect at the oligodendrocyte progenitor stage limiting subsequent oligodendrocyte maturation and preventing myelination. The identification of this naturally occurring model provides a potential resource for investigating the mechanisms and therapeutic targets for specificgenetic variants.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/41701830/